Compare Stocks › ABBV vs NTRS

AbbVie Inc. (ABBV) vs Northern Trust Corporation (NTRS): Which Is the Better Buy in 2026?

As of 2026-11-02, ABBV is overvalued at $295, with a DCF intrinsic value of $172 and a margin of safety of -71%. NTRS is fairly valued at $169, with an intrinsic value of $195 and a margin of safety of 13%. Of the two, NTRS has the wider margin of safety.

ABBV
AbbVie Inc.
$294.89
VS
NTRS
Northern Trust Corporation
$169.16

Rewards

ABBV
  • ★AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Gross margin of 73.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
NTRS
  • ★Free cash flow has grown at a 41.8% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • ★Share count has been reduced by 11% over the past 4 years through buybacks, increasing each share's claim on earnings.
  • ★Each dollar of retained earnings has created $1.54 of earning power — management is creating shareholder value.

Risks

ABBV
  • ⚠Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • ⚠Insiders have sold $8.2M worth of stock in the past 3 months — significant insider liquidation.
  • ⚠Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
NTRS
  • ⚠Gross margin of 0.0% is low, suggesting a competitive or commodity-like market with limited pricing power.
  • ⚠Altman Z-Score of 0.27 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
  • ⚠Insiders have sold $3.9M worth of stock in the past 3 months — significant insider liquidation.

Key Valuation Metrics

Learn more →
ABBV
NTRS
Valuation
N/A
Free Cash Flow
N/A
N/A
FCF Yield
N/A
50.67
Trailing P/E
13.27
18.24
Forward P/E
12.97
Quality & Moat
29.08%
ROIC
15.47%
N/A
ROE
18.44%
73.72%
Gross Margin
0.00%
0.60
PEG Ratio
0.93
Balance Sheet Safety
N/A
Net Debt / Equity
N/A
N/A
Interest Coverage
N/A
2.03
Net Debt / EBITDA
N/A
2.35%
Dividend Yield
2.08%
ABBV: 4Ties: 1NTRS: 2
ABBVNTRS

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

NTRS

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
NTRS
$2.39
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$2.93B
Δ Market Cap
+$7.01B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
71.5% Overvalued
Price is 71.5% above estimated fair value
Current Price: $294.89
Fair Value: $172.00
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
NTRS
13.3% Margin of Safety
Price is 13.3% below estimated fair value
Current Price: $169.16
Fair Value: $195.15
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

NTRS

Requires positive FCF to compute implied growth rate.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
NTRS
54/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with reinvestment efficiency as the key competitive advantage. Improving margin stability would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
NTRS
-2.59
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 77.4%Retail & Other 22.5%
No. of Institutional Holders5,303
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
NTRS
Insiders 0.9%Institutions 87.2%Retail & Other 12.0%
No. of Institutional Holders1,400
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
NTRS
0
Buys (3M)
5
Buys (12M)
Total value (12M): $769,611
MORITZ ROBERT EDWARD JR.
Director
$45,790
@ $179.57 · 2026-07-29
MORITZ ROBERT EDWARD JR.
Director
$37,442
@ $166.41 · 2026-05-01
PETRINO RICHARD
Director
$148,910
@ $148.91 · 2026-02-05
MORITZ ROBERT EDWARD JR.
Director
$37,203
@ $151.85 · 2026-02-02
MORITZ ROBERT EDWARD JR.
Director
$500,266
@ $128.57 · 2025-11-04
MORITZ ROBERT EDWARD JR.
Director
$34,198
@ $126.66 · 2025-10-27
MORITZ ROBERT EDWARD JR.
Director
$32,343
@ $126.34 · 2025-08-13
MORITZ ROBERT EDWARD JR.
Director
$10,261
@ $91.62 · 2025-04-24
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
1
Sells (3M)
4
Sells (12M)
Total value (12M): $18.92M
DONOGHOE NICHOLAS
Officer
$8.18M
@ $250.00 · 2026-08-14
PURDUE DAVID RYAN
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
NTRS
2
Sells (3M)
12
Sells (12M)
Total value (12M): $10.68M
LEVY SUSAN COHEN
General Counsel
$3.52M
@ $168.25 · 2026-10-26
SOUTH THOMAS A
Officer
$332,820
@ $184.90 · 2026-08-24
HALLINAN AENGUS
Officer
$613,880
@ $167.36 · 2026-06-03
BELLOWS CLIVE
Officer
$462,056
@ $165.02 · 2026-04-24
GIBSON GUY
Officer
$428,452
@ $142.39 · 2026-03-05
FOX DAVID W JR
Chief Financial Officer
$468,362
@ $143.89 · 2026-03-04
FOX DAVID W JR
Chief Financial Officer
$208,872
@ $144.05 · 2026-02-25
BELLOWS CLIVE
Officer
$166,758
@ $145.26 · 2026-02-12
GIBSON GUY
Officer
$153,769
@ $147.43 · 2026-02-12
SOUTH THOMAS A
Officer
$695,150
@ $139.03 · 2025-12-11
LANDERS JOHN P.
Officer
$95,252
@ $124.35 · 2025-11-17
LEVY SUSAN COHEN
General Counsel
$3.54M
@ $128.13 · 2025-11-04
PARKER TERESA A
Officer
$997,458
@ $131.21 · 2025-07-31
HALLINAN AENGUS
Officer
$528.00
@ $105.60 · 2025-05-22
CONWAY KELLEY
Officer
$52,640
@ $105.28 · 2025-05-12
FOX DAVID W JR
Chief Financial Officer
$535,772
@ $105.55 · 2025-05-12
PARKER TERESA A
Officer
$650,710
@ $100.62 · 2025-05-09
BELLOWS CLIVE
Officer
$329,835
@ $99.95 · 2025-05-08
SOUTH THOMAS A
Officer
$429,852
@ $113.00 · 2025-02-19
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(72/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
NTRS
FearGreed
😐Neutral(56/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (72)
NTRS
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
View ABBV Full AnalysisView NTRS Full Analysis

Frequently Asked Questions: ABBV vs NTRS

Is AbbVie Inc. or Northern Trust Corporation more undervalued in 2026?▼

Based on our discounted cash flow model, NTRS trades at a 13.3% margin of safety (intrinsic value $195 vs. price $169), compared to ABBV's -71.5% margin of safety (intrinsic $172 vs. $295).

Which stock has a wider economic moat, AbbVie Inc. or Northern Trust Corporation?▼

ABBV scores 82/100 (Wide moat), while NTRS scores 54/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Northern Trust Corporation in financial distress?▼

NTRS's Altman Z-Score of 0.3 places it in the Distress zone, signaling elevated bankruptcy risk. ABBV scores 2.4 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or Northern Trust Corporation?▼

ABBV earns 29.1% ROIC versus NTRS's 15.5%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Northern Trust Corporation's?▼

NTRS's dividend earns a safety score of 91/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). NTRS has raised its dividend for 2 consecutive years.

ABBV vs NTRS: Which Is the Better Buy in 2026? | SafetyMargin.io